Allogene Therapeutics Company Contacts

Allogene Therapeutics

www.allogene.com
Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) products for cancer and autoimmune disease. For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines Please... Read More
Contacts

Country

United States

City

South San Francisco

Headquarters

South San Francisco, California

Profile

Founded

2017

Industry

Biotechnology

Size

201 - 500

Specialties

oncology, cancer, biotechnology, immunotherapy, CAR T, autoimmune

Funding

Total Rounds

5

Last Round

Mon May 13 2024

Last Round Series

Post IPO equity

Last Round Raised

$ 110,000,000